Skip to main content
Equibles

SUS · Surgical Science Sweden AB

Use SUS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SUS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
50.0500 SEK -1.1500 (-2.25%) At close · Oct 2
Rebalance outlook locked
Market Cap
2.52B SEK
Shares
51.03M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Investor day
Close50.0500 SEK Open51.2000 SEK Day50.0000–51.2000 SEK 52W close23.9200–91.7500 SEK Avg vol 30d194K Last earningsFeb 23, 2028 DataMay 2020–Oct 2026

Raw chart and full-history price indicators begin at the captured split on May 25, 2020; bars on opposite sides are not compared.

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its 52-week range
Range low 23.9200 SEK Now 50.0500 SEK · 39% Range high 91.7500 SEK
vs 200-day avg +43% vs 50-day avg +10%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

Raw-price comparisons begin at the captured split on May 25, 2020; windows that need an earlier baseline remain unavailable.

5D 20D 120D MTD YTD
FNSE:SUS +1.4% -2.1% +45.8% -2.3% +54.0%

Exchange listing

Market
FNSE
Ticker
SUS
ISIN
SE0014428512
Security
—
Trading currency
SEK

Company

Website
https://www.surgicalscience.com/
Investor relations
https://surgicalscience.com/investor-relations/

Other listings of this company

No other verified listings are available.

Recent dividends

No verified dividend payments are available for this listing yet.

Upcoming investor events

DateEventType
2026-11-12 00:00 UTC Interim report, January-September 2026 Results publication
2027-02-23 00:00 UTC Year-end report 2026 Results publication
2027-05-18 00:00 UTC Interim report, January–March 2027 Results publication
2027-08-18 00:00 UTC Interim report, January–June 2027 Results publication
2027-11-11 00:00 UTC Interim report, January–September 2027 Results publication
2028-02-23 00:00 UTC Year-end report 2027 Results publication

Earnings calls

  • Earnings call · Q4 2027 2028-02-23 Scheduled
    Year-end report 2027
  • Earnings call · Q3 2027 2027-11-11 Scheduled
    Interim report, January–September 2027
  • Earnings call · Q2 2027 2027-08-18 Scheduled
    Interim report, January–June 2027
  • Earnings call · Q1 2027 2027-05-18 Scheduled
    Interim report, January–March 2027
  • Earnings call · Q4 2026 2027-02-23 Scheduled
    Year-end report 2026
  • Earnings call · Q3 2026 2026-11-12 Scheduled
    Interim report, January-September 2026